Storia in 2 fonti

Maker suggests Wegovy lowers heart risks more than similar drugs - UPI.com

Weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, research by drug manufacturer Novo Nordisk suggests.

Raccontata da

cnbc.com

upi.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

upi.comStai leggendo10 mesi fa

Maker suggests Wegovy lowers heart risks more than similar drugs - UPI.com

Weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, research by drug manufacturer Novo Nordisk suggests.

originale

cnbc.com10 mesi fa

Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes

Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington's push to get firms to lower drug prices and move manufacturing stateside.

Leggi questa versione → originale

Timeline cronologica

lunedì 1 settembre 2025·cnbc.com
Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes
Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington's push to get firms to lower drug prices and move manufacturing stateside.
mercoledì 3 settembre 2025·upi.com
Maker suggests Wegovy lowers heart risks more than similar drugs - UPI.com
Weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, research by drug manufacturer Novo Nordisk suggests.